SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-005619
Filing Date
2020-01-21
Accepted
2020-01-21 17:23:34
Documents
14
Period of Report
2020-01-16
Items
Item 1.03: Bankruptcy or Receivership
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203649d1_8k.htm   iXBRL 8-K 30337
2 EXHIBIT 99.1 tm203649d1_ex99-1.htm EX-99.1 11817
6 GRAPHIC tm203649d1_ex99-1img01.jpg GRAPHIC 8760
  Complete submission text file 0001104659-20-005619.txt   232665

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvlnf-20200116.xsd EX-101.SCH 3189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlnf-20200116_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlnf-20200116_pre.xml EX-101.PRE 22711
11 EXTRACTED XBRL INSTANCE DOCUMENT tm203649d1_8k_htm.xml XML 3520
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 20537075
SIC: 2834 Pharmaceutical Preparations